Certified by Founder Lodge
EyeBio
United Kingdom - London
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with si
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 15 ,2023 | Series A | $65,000,000 |
Bain Capital
Vertex Ventures HC
SV Health Investors
Omega Funds
Samsara BioCapital
JEITO
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
